Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
Background: The Global Typhoid Genomics Consortium was established to bring together
the typhoid research community to aggregate and analyse Salmonella enterica serovar …
the typhoid research community to aggregate and analyse Salmonella enterica serovar …
Evaluating the relationship between ciprofloxacin prescription and non-susceptibility in Salmonella Typhi in Blantyre, Malawi: an observational study
PM Ashton, AC Chirambo, JE Meiring, PD Patel… - The Lancet …, 2024 - thelancet.com
Background Ciprofloxacin is the first-line drug for treating typhoid fever in many countries in
Africa with a high disease burden, but the emergence of non-susceptibility poses a …
Africa with a high disease burden, but the emergence of non-susceptibility poses a …
The rapid emergence of Salmonella Typhi with decreased ciprofloxacin susceptibility following an increase in ciprofloxacin prescriptions in Blantyre, Malawi
Ciprofloxacin is the first-line drug for treating typhoid fever in many high burden countries in
Africa, but the emergence of non-susceptibility poses a grave challenge to public health …
Africa, but the emergence of non-susceptibility poses a grave challenge to public health …